Immediate Impact
9 standout
Citing Papers
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
2024 Standout
Glioblastoma Therapy: Past, Present and Future
2024 Standout
Works of Logan Zhang being referenced
The IAP antagonist birinapant enhances chimeric antigen receptor T cell therapy for glioblastoma by overcoming antigen heterogeneity
2022
High-Affinity Chimeric Antigen Receptor With Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Logan Zhang | 51 | 26 | 22 | 33 | 27 | 5 | 105 | |
| Omid Shah | 62 | 52 | 17 | 53 | 19 | 7 | 192 | |
| Yi Lin | 36 | 30 | 8 | 28 | 93 | 7 | 168 | |
| R Facchini | 31 | 43 | 7 | 31 | 22 | 5 | 102 | |
| Noha Gerges | 67 | 13 | 44 | 64 | 45 | 6 | 175 | |
| Vasco Pinto | 51 | 10 | 4 | 54 | 13 | 6 | 151 | |
| Elisa Bergaggio | 55 | 29 | 8 | 81 | 23 | 6 | 176 | |
| Christofer Bäcklin | 22 | 30 | 18 | 88 | 5 | 8 | 172 | |
| Melitta Kitzwoegerer | 17 | 4 | 6 | 38 | 27 | 6 | 113 | |
| William Sperduto | 21 | 11 | 24 | 48 | 12 | 6 | 112 | |
| Lauren Hanson | 35 | 9 | 7 | 24 | 41 | 5 | 88 |
All Works
Loading papers...